Inventor · disambiguated record
Stefan Scherer
Also filed as: SCHERER STEFAN · SCHERER STEFAN A
10 granted patents·43 pending applications·25 citations·filing 2010–2024
81Inventor score
Files withHOFFMANN LA ROCHE29EMBODIED INC15GENENTECH INC5CHILDREN'S HOSPITAL MEDICAL CENTER1DE HAAS SANNE LYSBET1
Top patents by PatentIndex Score
53 records- 0186US9691411B2System and method for assessing suicide risk of a patient based upon non-verbal characteristics of voice dataCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2014·Granted Jun 27, 2017·25 cites·6 claims
- 0280US2023324879A1Systems and methods to adapt and optimize human-machine interaction using multimodal user-feedbackEMBODIED INC·Filed 2023·Application pending·0 cites
- 0379US11709475B2Systems and methods to adapt and optimize human-machine interaction using multimodal user-feedbackEMBODIED INC·Filed 2022·Granted Jul 25, 2023·0 cites·20 claims
- 0471US2025001615A1Systems and methods for authoring and modifying presentation conversation files for multimodal interactive computing devices / artificial compansionsEMBODIED INC·Filed 2024·Application pending·0 cites
- 0568US11526147B2Systems and methods to adapt and optimize human-machine interaction using multimodal user-feedbackEMBODIED INC·Filed 2021·Granted Dec 13, 2022·0 cites·28 claims
- 0665US12197876B2Systems and methods for short- and long-term dialog management between a robot computing device/digital companion and a userEMBODIED INC·Filed 2024·Granted Jan 14, 2025·0 cites·19 claims
- 0764US2013171135A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0864US2013183300A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0964US2013243758A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1063US2013336960A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1163US2014017231A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1263US2014017232A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1363US2013336959A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1463US2014193397A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1563US2014056874A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1663US2014056875A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1763US2013344059A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1863US2014023639A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1958US2014056876A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2058US2014023640A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2157US12083690B2Systems and methods for authoring and modifying presentation conversation files for multimodal interactive computing devices/artificial companionsEMBODIED INC·Filed 2021·Granted Sep 10, 2024·0 cites·19 claims
- 2257US2013344060A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2356US12080297B2Systems and methods for adaptive human-machine interaction and automatic behavioral assessmentEMBODIED INC·Filed 2023·Granted Sep 3, 2024·0 cites·16 claims
- 2456US10969763B2Systems and methods to adapt and optimize human-machine interaction using multimodal user-feedbackEMBODIED INC·Filed 2019·Granted Apr 6, 2021·0 cites·23 claims
- 2554US2014302019A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2653US12019993B2Systems and methods for short- and long-term dialog management between a robot computing device/digital companion and a userEMBODIED INC·Filed 2021·Granted Jun 25, 2024·0 cites·18 claims
- 2753US2025104226A1Automated ultrasound imaging analysis and feedbackGEONOMY LTD·Filed 2022·Application pending·0 cites
- 2852US2014341893A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerGENENTECH INC·Filed 2014·Application pending·0 cites
- 2951US2013183303A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3051US2013121999A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 3151US2013183301A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3251US2013195857A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3351US2013183302A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3451US2013108626A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 3550US2013315899A1Methods and compositions for diagnostic use in cancer patientsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3650US2015004136A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 3749US2022207426A1Method of semi-supervised data collection and machine learning leveraging distributed computing devicesEMBODIED INC·Filed 2021·Application pending·0 cites
- 3848US12136431B2Multimodal beamforming and attention filtering for multiparty interactionsEMBODIED INC·Filed 2021·Granted Nov 5, 2024·0 cites·19 claims
- 3948US2015352204A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4046US2023274743A1Methods and systems enabling natural language processing, understanding, and generationEMBODIED INC·Filed 2022·Application pending·0 cites
- 4145US2013177554A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4245US2014294768A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4345US2013183304A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4445US2013171134A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4544US11557297B2Systems and methods for adaptive human-machine interaction and automatic behavioral assessmentEMBODIED INC·Filed 2019·Granted Jan 17, 2023·0 cites·23 claims
- 4644US2017066822A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 4744US2022241985A1Systems and methods to manage conversation interactions between a user and a robot computing device or conversation agentEMBODIED INC·Filed 2021·Application pending·0 cites
- 4844US2022093000A1Systems and methods for multimodal book readingEMBODIED INC·Filed 2021·Application pending·0 cites
- 4942US2014099302A1Methods to identify responsive patientsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 5040US2011064732A1Methods and compositions for diagnostic use in cancer patientsDE HAAS SANNE LYSBET·Filed 2010·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →